phe885
novartis
['phe885']
next generation car t cells phe885 presented by dr. adam sperling in triple refractory heavily pretreated rrmm patients, 33% with emd. 10 day door to door manufacturing time! 100% orr at active dose. watch for crs and icans at similar rates to approved car t. #asco23 
Multiple Myeloma Oncologist